Profilo
Carol Nast formerly worked at CohBar, Inc., as Independent Director from 2021 to 2023, Tecan Genomics, Inc., as Chief Operating Officer, Alluence Capital Advisors, Inc., as President-Enterprise from 2009 to 2020, and Mind Medicine (MindMed), Inc., as Chief Operating Officer.
Precedenti posizioni note di Carol Nast
| Società | Posizione | Fine |
|---|---|---|
| COHBAR | Direttore/Membro del Consiglio | 10/11/2023 |
Alluence Capital Advisors, Inc.
Alluence Capital Advisors, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01/01/2020 |
Tecan Genomics, Inc.
Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides genomics sample preparation solutions | Direttore operativo | - |
| DEFINIUM THERAPEUTICS, INC. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Tecan Genomics, Inc.
Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides genomics sample preparation solutions | Electronic Technology |
CohBar, Inc.
CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
Alluence Capital Advisors, Inc.
Alluence Capital Advisors, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Mind Medicine (MindMed), Inc.
Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
















